<?xml version="1.0" encoding="UTF-8"?>
<ref id="B89-jcm-09-01917">
 <label>89.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Moore</surname>
    <given-names>H.B.</given-names>
   </name>
   <name>
    <surname>Barrett</surname>
    <given-names>C.D.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>E.E.</given-names>
   </name>
   <name>
    <surname>McIntyre</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>P.K.</given-names>
   </name>
   <name>
    <surname>Talmor</surname>
    <given-names>D.S.</given-names>
   </name>
   <name>
    <surname>Moore</surname>
    <given-names>F.A.</given-names>
   </name>
   <name>
    <surname>Yaffe</surname>
    <given-names>M.B.</given-names>
   </name>
  </person-group>
  <article-title>Is There a Role for Tissue Plasminogen Activator as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome?</article-title>
  <source>J. Trauma Acute Care Surg.</source>
  <year>2020</year>
  <volume>88</volume>
  <fpage>713</fpage>
  <lpage>714</lpage>
  <pub-id pub-id-type="doi">10.1097/TA.0000000000002694</pub-id>
  <?supplied-pmid 32281766?>
  <pub-id pub-id-type="pmid">32281766</pub-id>
 </element-citation>
</ref>
